Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARAMBA-1: SLAMF7 CAR-T in Multiple Myeloma
NCT04499339Phase 2Active, not recruiting
- Start
- Jul 2020
- Primary completion
- Dec 2025
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 3
01
Overview
A Phase 2 trial of SLAMF7 CAR-T in multiple myeloma (MM). Started Jul 2020; status: active, not recruiting.
02
Drugs
SLAMF7 CAR-T
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04499339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499339.